Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Lisa Burnapp"'
Written by educators and renal nurses with extensive experience of clinical practice the Oxford Handbook of Renal Nursing is a concise, current and evidence-based guide to the care of patients with renal disease. This practical and thorough resource
Autor:
Tiyi Morris, Hannah Maple, Sam Norton, Joseph Chilcot, Lisa Burnapp, Heather Draper, Nizam Mamode, Paul McCrone
Publikováno v:
Transplantation. 106:2137-2142
End-stage kidney disease is a significant burden on the healthcare systems of many countries, and this is likely to continue because of an increasingly aging and comorbid population. Multiple studies have demonstrated a significant clinical benefit i
Autor:
Aisling E. Courtney, Greg Moorlock, Kristof Van Assche, Lisa Burnapp, Nizam Mamode, Annette Lennerling, Frank J. M. F. Dor
Publikováno v:
Transplant international
Living donor transplantation is the optimal treatment for suitable patients with end-stage kidney disease. There are particular advantages for older individuals in terms of elective surgery, timely transplantation, and early graft function. Yet, desp
Autor:
Willem Weimar, David van Dellen, Dorthe Slaats, Frank J M F Dor, Annette Lennerling, Lisa Burnapp, Kristof Van Assche, Nizam Mamode, Willij C. Zuidema, Franco Citterio
Publikováno v:
Clinical Kidney Journal
Clinical Kidney Journal, 13(2), 159-165. Oxford University Press
Clinical Kidney Journal, 13(2), 159-165. Oxford University Press
BackgroundLiving donor kidney transplantation (LDKT) is the preferred treatment for patients with end-stage renal disease and unspecified living kidney donation is morally justified. Despite the excellent outcomes of LDKT, unspecified kidney donation
Publikováno v:
Transplant International, 35:10091. Wiley-Blackwell Publishing Ltd
Anonymous living donor kidney transplantation (LDKT) is performed in many countries and policies on anonymity differ. The UK is the only European country with a conditional policy, allowing pairs to break anonymity post-transplant. There is little ev
Autor:
Nizam Mamode, Kristof Van Assche, Lisa Burnapp, Aisling Courtney, David van Dellen, Mireille Houthoff, Hannah Maple, Greg Moorlock, Frank J. M. F. Dor, Annette Lennerling
Publikováno v:
Transplant international
Transplant International, 35:10131. Wiley-Blackwell Publishing Ltd
Transplant International, 35:10131. Wiley-Blackwell Publishing Ltd
Clinical teams understandably wish to minimise risks to living kidney donors undergoing surgery, but are often faced with uncertainty about the extent of risk, or donors who wish to proceed despite those risks. Here we explore how these difficult dec
Autor:
Rachel Hogg, Stijn C van de Laar, Frank J M F Dor, Vassilios Papalois, Lisa Burnapp, Matthew Robb
Publikováno v:
Annals of surgery. 274(5)
OBJECTIVE To assess the impact of CIT on living donor kidney transplantation (LDKT) outcomes in the UKLKSS versus outside the scheme. BACKGROUND LDKT provides the best treatment option for end-stage kidney disease patients. end-stage kidney disease p
Autor:
Alessandro Nanni Costa, Pavel Chromy, Lisa Burnapp, Dirk Kuypers, David F. Manlove, Xenia Klimentova, Bart Smeulders, Tommy Andersson, Pablo Delgado, Rachel J. Johnson, María O. Valentín, William Pettersson, Joris van de Klundert, Bernadette Haase, Piotr Dworczak, Ana Luiza d'Ávila Viana, Frits C. R. Spieksma, Aline C. Hemke, Péter Biró
Publikováno v:
European Journal of Operational Research, 291(2), 447-456. Elsevier
The complex multi-criteria optimisation problems arising in Kidney Exchange Programmes have received considerable attention both in practice and in the scientific literature. Whereas theoretical advancements are well reviewed and synthesised, this is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f49a376c0cb364ec714fdc222135eed
https://eprints.gla.ac.uk/194715/1/194715.pdf
https://eprints.gla.ac.uk/194715/1/194715.pdf
Autor:
Lisa Burnapp, Willij C. Zuidema, Kristof Van Assche, Frank J M F Dor, Annette Lennerling, Franco Citterio, Greg Moorlock, Nizam Mamode, David van Dellen
Publikováno v:
World Journal of Transplantation
Live donor kidney transplantation (LDKT) is the optimal treatment modality for end stage renal disease (ESRD), enhancing patient and graft survival. Pre-emptive LDKT, prior to requirement for renal replacement therapy (RRT), provides further advantag
Publikováno v:
Transplant International. 34
Antibody incompatibility is a barrier to living kidney transplantation; antibody incompatible transplantation (AIT) is an accepted treatment modality, albeit higher risk. This study aims to determine changes to clinical decision making and access to